5-hydroxypropafenone has been researched along with phenobarbital in 2 studies
| Studies (5-hydroxypropafenone) | Trials (5-hydroxypropafenone) | Recent Studies (post-2010) (5-hydroxypropafenone) | Studies (phenobarbital) | Trials (phenobarbital) | Recent Studies (post-2010) (phenobarbital) |
|---|---|---|---|---|---|
| 59 | 3 | 3 | 18,336 | 619 | 1,117 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
| Mizuochi, M; Morita, K; Yamaji, A; Yokoyama, T | 1 |
2 other study(ies) available for 5-hydroxypropafenone and phenobarbital
| Article | Year |
|---|---|
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
Stereoselectivity in the hydroxylation of propafenone enantiomers in mouse hepatic microsomes.
Topics: Animals; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme System; Hydroxylation; Kinetics; Male; Mice; Microsomes, Liver; Oxidation-Reduction; Phenobarbital; Propafenone; Stereoisomerism | 1994 |